Pharmalot Ed Silverman California governor decries ‘predatory’ pricing as he signs law to make EpiPen available
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Mylan quietly pushes effort to blunt impact of EpiPen pricing
Pharmalot Ed Silverman Bipartisan bill in Congress would require drug makers to justify, limit price hikes
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Mylan CEO to testify about EpiPen before Congress next week
Pharmalot Ed Silverman STAT Plus: Pharma suffers a setback in battle over Ohio drug pricing ballot measure
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Teva expects FDA to speed review of its generic EpiPen
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Are concerns about spending on orphan drugs overblown?
Pharmalot Ed Silverman Q&A: Allergan’s CEO speaks out on limiting drug prices. ‘Somebody had to take the first step’
Pharmalot Ed Silverman Allergan CEO promises to limit price hikes on drugs in a bid to rebuild the ‘social contract’
Pharmalot Ed Silverman Anyone see the rebates? Lawmakers accuse Mylan of underpaying Medicaid for EpiPen